| Short-acting beta-2-agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America JK Quint, S Arnetorp, JWH Kocks, M Kupczyk, J Nuevo, V Plaza, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (9), 2297 …, 2022 | 45 | 2022 |
| Development of the Asthma Impairment and Risk Questionnaire (AIRQ): a composite control measure KR Murphy, B Chipps, DA Beuther, RA Wise, W McCann, I Gilbert, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (7), 2263-2274. e5, 2020 | 38 | 2020 |
| The Asthma Impairment and Risk Questionnaire (AIRQ) control level predicts future risk of asthma exacerbations DA Beuther, KR Murphy, RS Zeiger, RA Wise, W McCann, J Reibman, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (12), 3204 …, 2022 | 20 | 2022 |
| Intraclass difference in pneumonia risk with fluticasone and budesonide in COPD: a systematic review of evidence from direct-comparison studies TP Lodise, J Li, HN Gandhi, G O’Brien, S Sethi International Journal of Chronic Obstructive Pulmonary Disease, 2889-2900, 2020 | 17 | 2020 |
| Real-world patterns and implications of short-acting β2-agonist use in patients with asthma in the United States N Lugogo, I Gilbert, J Tkacz, H Gandhi, N Goshi, MJ Lanz Annals of Allergy, Asthma & Immunology 126 (6), 681-689. e1, 2021 | 16 | 2021 |
| Mapping geographic variability of severe uncontrolled asthma in the United States: management implications ER Bleecker, H Gandhi, I Gilbert, KR Murphy, GL Chupp Annals of Allergy, Asthma & Immunology 128 (1), 78-88, 2022 | 14 | 2022 |
| Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma WC Moore, RA Panettieri Jr, J Trevor, DK Ledford, N Lugogo, W Soong, ... Annals of Allergy, Asthma & Immunology 125 (3), 294-303. e1, 2020 | 14 | 2020 |
| Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recall BE Chipps, KR Murphy, RA Wise, WA McCann, DA Beuther, J Reibman, ... Annals of Allergy, Asthma & Immunology 128 (5), 544-552. e3, 2022 | 13 | 2022 |
| Relationship between asthma control as measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and patient perception of disease status, health-related quality of life … J Reibman, BE Chipps, RS Zeiger, DA Beuther, RA Wise, W McCann, ... Journal of Asthma and Allergy, 59-72, 2023 | 8 | 2023 |
| The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control B Chipps, RS Zeiger, DA Beuther, J Reibman, RA Wise, W McCann, ... Annals of Allergy, Asthma & Immunology 131 (4), 436-443. e1, 2023 | 7 | 2023 |
| The use of short-acting bronchodilators and cost burden of asthma across Global Initiative for Asthma–based severity levels: Insights from a large US commercial and managed … M Pollack, H Gandhi, J Tkacz, M Lanz, N Lugogo, I Gilbert Journal of Managed Care & Specialty Pharmacy 28 (8), 881-891, 2022 | 7 | 2022 |
| The Quality of Care and Economic Burden of COPD in the United States: Considerations for Managing Patients and Improving Outcomes. DL Larsen, H Gandhi, M Pollack, N Feigler, S Patel, RA Wise American Health & Drug Benefits 15 (2), 2022 | 7 | 2022 |
| Suboptimal control of asthma among diverse patients: a US mixed methods focus group study M George, Z Balantac, C Gillette, N Farooqui, T Tervonen, C Thomas, ... Journal of Asthma and Allergy, 1511-1526, 2022 | 4 | 2022 |
| Assessment of asthma morbidity by US patients, specialists, Asthma Control Test™, and Asthma Impairment and Risk Questionnaire™ K Murphy, RS Zeiger, DA Beuther, J Reibman, RA Wise, W Mccann, ... European Respiratory Journal 56 (suppl 64), 2020 | 4 | 2020 |
| A discrete choice experiment to assess patient preferences for asthma rescue therapy and disease management E Israel, N Farooqui, C Gillette, I Gilbert, H Gandhi, T Tervonen, ... The Journal of Allergy and Clinical Immunology: In Practice 11 (9), 2781 …, 2023 | 3 | 2023 |
| Patterns of care in the management of high-risk COPD in the US (2011–2019): an observational study for the CONQUEST quality improvement program M Kerr, Y Tarabichi, A Evans, D Mapel, W Pace, V Carter, A Couper, ... The Lancet Regional Health–Americas 24, 2023 | 2 | 2023 |
| Number of patient-reported asthma triggers predicts uncontrolled disease among specialist-treated patients with severe asthma BE Chipps, W Soong, RA Panettieri Jr, W Carr, H Gandhi, W Zhou, ... Annals of Allergy, Asthma & Immunology 130 (6), 784-790. e5, 2023 | 2 | 2023 |
| PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population G Criner, F Martinez, H Gandhi, N Feigler, B Pyenson, M Emery, U Gupta, ... Journal of Health Economics and Outcomes Research 10 (1), 20, 2023 | 2 | 2023 |
| Assessing Asthma Control in the United States by Examining the Relationships Between Short-Acting Beta2-Agonist and Systemic Corticosteroid Use ER Bleecker, KR Murphy, HN Gandhi, I Gilbert, G Chupp A48. ENVIRONMENTAL ASTHMA, A1818-A1818, 2020 | 2 | 2020 |
| Confirmatory cross-sectional validation of the Asthma Impairment and Risk Questionnaire RA Wise, B Chipps, KR Murphy, DA Beuther, J Reibman, W McCann, ... The Journal of Allergy and Clinical Immunology: In Practice 11 (11), 3531 …, 2023 | 1 | 2023 |
Maureen George PhD RN AE-C FAANProfessor of Nursing, Columbia University School of Nursing在 cumc.columbia.edu 的电子邮件经过验证
